|
|
Article: Antares Pharma Presents Before the Financial Analysts and Money Managers Society in New York City; - Reports 2002 Revenues Rose 14% - Cash Burn Rate Reduced Nearly 50% - Pursuing Partnerships with Leading Pharmaceutical Companies - 2003 Goals to Significantly Grow Gross Revenues and be Cash Flow Positive by 2004.
- Article from:
- PR Newswire
- Article date:
- March 4, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Antares Pharma, Inc. , in an after market presentation before the Financial Analysts and Money Managers Society of New York, reported that revenues for 2002 reached approximately $4.0 million, up 14% from $3.5 million in 2001, and that the Company's monthly burn rate has been reduced by nearly 50% from one year ago.
Dr. Roger G. Harrison, Chief Executive Officer and President of Antares Pharma, stated that the Company's goals for 2003 include "reaching decision points with ten high-possibility partnerships currently being pursued with pharmaceutical companies in the U.S. and overseas." Moreover, he added that the goal is to "consummate at least two major ...